HOOK — Hookipa Pharma Balance Sheet
0.000.00%
- $10.25m
- -$29.43m
- $43.95m
Annual balance sheet for Hookipa Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 143 | 65.9 | 112 | 117 | 39.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 20.7 | 21.2 | 22 | 19.3 | 23.7 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 172 | 102 | 147 | 147 | 80.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 14 | 22.1 | 22 | 13.2 | 1.06 |
Other Long Term Assets | |||||
Total Assets | 188 | 126 | 170 | 161 | 82.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 21.1 | 27.7 | 35.6 | 42 | 24.7 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 31.7 | 36.5 | 67.9 | 71.5 | 31.3 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 156 | 89.6 | 103 | 89.9 | 51.2 |
Total Liabilities & Shareholders' Equity | 188 | 126 | 170 | 161 | 82.5 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |